The AI Edge in Biopharma: Greg Meyers on How BMS Applies AI for Smarter Drug Discovery

About this episode

Greg Meyers discusses the application of AI in drug discovery at BMS.

From coder to C-suite, Greg understands the pace of technological change, prioritizes highest value over lowest cost, and stays close to innovation. At BMS, he’s advancing both in-house AI applications and AI-powered R&D—unlocking hidden data patterns that can turn serendipity into systematic discovery.

People in this episode

Guest: Greg Meyers

Topics covered

• AI in biopharma
• drug discovery
• innovation
• R&D
• data patterns

Keywords

• AI
• biopharma
• drug discovery
• R&D
• innovation
• data patterns

Mentioned in this episode

Organizations: BMS

More episodes of The Future of Healthcare AI

• Spanning Every Surface: Google Cloud’s Aashima Gupta on AI, Access, and Adaptive Healthcare · May 25, 2026 · 30 min
• Medicare meets AI: Andrew Toy on How Clover Health Superpowers Clinicians and Enables Earlier Intervention · May 10, 2026 · 35 min
• Reprogramming Age: Jacob Kimmel on How NewLimit Uses AI to Extend Healthspans · May 3, 2026 · 39 min
• At the Intersection: Jacob and Eli Berlin on How Terray Merges Chemistry and Compute to Drive Drug Discovery · January 26, 2026 · 36 min
• Where Pharma Wins: Jaswinder Chadha on How Axtria Uses AI to Drive Commercial Ops and Outcomes · January 5, 2026 · 27 min
• Operationalizing AI: Aman Wasan on How the ArisGlobal Digital Platform Powers Safer, Smarter Therapies · November 17, 2025 · 28 min